<<
>>

5.1. Research of efficiency of antiviral therapy HGV at children and teenagers.

The group of patients with HGV, receiving PVT, included 24 patients: girls - 9 (37,5 %), boys - 15 (62,5 %). The overwhelming majority was made by teenagers - 17 patients (70,8 %). Statistically significant differences at the age of the therapy beginning (r 0,05 24 week 2 18,2 2 28,6 > 0,05 36 week 1 9,1 2 28,6 > 0,05 Leukopenia 4 week 4 36,4 2 28,6 > 0,05 12 week 4 36,4 2 28,6 > 0,05 24 week 1 9,1 1 14,2 > 0,05 36 week 0 0 1 14,2 > 0,05 Thrombocytopenia 4 week 1 9,1 1 14,2 > 0,05 12 week 3 27,3 1 14,2 > 0,05 24 week 1 9,1 2 28,6 > 0,05 36 week 1 9,1 0 0 > 0,05 G iperbilirubinemija 4 week 1 9,1 0 0 > 0,05 12 week 1 9,1 1 14,2 > 0,05

24 week 0 0 0 0 > 0,05
36 week 0 0 0 0 > 0,05
Rising of level ALT 4 week 2 18,2 1 14,2 > 0,05
12 week 1 9,1 1 14,2 > 0,05
24 week 2 18,2 2 28,6 > 0,05
36 week 1 9,1 0 0 > 0,05
Rising of level of nuclear heating plant 4 week 3 27,3 2 28,6 > 0,05
12 week 2 18,2 1 14,2 > 0,05
24 week 1 9,1 1 14,2 > 0,05
36 week 0 0 1 14,2 > 0,05
Hypoproteinemia 4 week 6 54,5 5 71,4 > 0,05
12 week 1 9,1 4 57,1 > 0,05
24 week 3 27,3 2 28,6 > 0,05
36 week 2 18,2 1 14,2 > 0,05
Hypoalbuminemia 4 week 2 18,2 2 28,6 > 0,05
12 week 1 9,1 1 14,2 > 0,05
24 week 2 18,2 1 14,2 > 0,05
36 week 1 9,1 0 0 > 0,05
Depression PTI 4 week 0 0 0 0 > 0,05
12 week 0 0 2 28,6 > 0,05
24 week 3 27,3 1 14,2 > 0,05
36 week 1 9,1 1 14,2 > 0,05

Statistically significant differences between dynamics of changes of growth and masses of a body at patients with HGV, receiving various schemes PVT (r

<< | >>
Scientific source Dmitriev Tatyana Gennadevna.
CHRONIC VIRUS HEPATITISES At CHILDREN And TEENAGERS In REGION GIPERENDEMICHNOM. The PROGRAM of PERFECTION of RENDERING of the MEDIKO-SOCIAL HELP. The dissertation on competition of a scientific degree of the doctor of medical sciences. Yakutsk - 2014. 2014


Ñêà÷àòü îðèãèíàë èñòî÷íèêà

Other medical related information 5.1. Research of efficiency of antiviral therapy HGV at children and teenagers.:

  1. the Maintenance
  2. INTRODUCTION
  3. 1.5. The general principles of antiviral therapy of chronic hepatitises at children and teenagers.
  4. treatment of a chronic hepatitis With
  5. 1.6. Mediko-social problems of chronic hepatitises at children and teenagers.
  6. 2.1. Research materials
  7. 2.2. Research methods
  8. Chapter 5. RESEARCH of EFFICIENCY of ANTIVIRAL THERAPY of CHRONIC HEPATITISES At CHILDREN And TEENAGERS
  9. 5.1. Research of efficiency of antiviral therapy HGV at children and teenagers.
  10. 5.3.2. Forecasting of efficiency of antiviral therapy HGS
  11. forecasting of probability of conservation of effect of antiviral therapy at HG a method of the analysis of survival rate
  12. Chapter 7. The PROGRAM CONCEPT «CHRONIC HEPATITISES At CHILDREN And TEENAGERS»
  13. THE LITERATURE LIST
  14. CHAPTER 4. RESULTS OF STUDYING OF THE MICROFLORA OF THE STOMATOPHARYNX AND THE INTESTINE BY MEANS OF THE BACTERIOLOGICAL METHOD OF RESEARCH WITH DEFINITION OF FACTORS OF PATHOGENICITY OF STAPHILOCOCCUSES AND DEGREES OF THE ENDOGENOUS INTOXICATION
  15. object of research
  16. Chapter 3.2. Efficiency and safety etanertsepta at children with JUIA.
  17. Chapter 4 of Feature of function of external breath at observable children with a mucoviscidosis (results of own researches)
  18. Chapter 7 DISCUSSION of RESULTS of RESEARCH
  19. research Methods